Myeloid-Lymphoid Leukemia Protein [protoonkogenní protein MLL]
- Terms
-
protein 1 akutní lymfoblastické leukémie
protein HRX
protein myeloidní a lymfoidní leukémie
protein myeloidní-lymfoidní leukémie
-
Acute Lymphoblastic Leukemia Protein 1
Mixed-Lineage Leukemia Protein
MLL Proto-Oncogene Protein
Proto-Oncogene Proteins MLL
Zinc Finger Protein HRX
Myeloid-lymphoid leukemia protein is a transcription factor that maintains high levels of HOMEOTIC GENE expression during development. The GENE for myeloid-lymphoid leukemia protein is commonly disrupted in LEUKEMIA and combines with over 40 partner genes to form FUSION ONCOGENE PROTEINS.
- DUI
- D051788 MeSH Browser
- CUI
- M0209080
- History note
- 2006(1992)
- Public note
- 2006; MYELOID-LYMPHOID LEUKEMIA PROTEIN was indexed under DNA-BINDING PROTEINS & PROTO-ONCOGENE PROTEINS & TRANSCRIPTION FACTORS 1992-2005
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AN
- analysis 1
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 1
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 4
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 29
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 1
- ME
- metabolism 9
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0